Home
Market
Idorsia submits a new drug application to the FDA
Market

Idorsia submits a new drug application to the FDA

1 year ago No Comments

This post was originally published on this site

Aprocitentan is intended to be used in the treatment of patients with difficult-to-control hypertension. Idorsia included data from a comprehensive clinical and non-clinical development program in the application.

Related Posts

About The Author

admin
More from this Author